{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:40:18Z","timestamp":1791164418020,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ygyno.2011.02.020","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T01:54:10Z","timestamp":1306202050000},"page":"434-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis"],"prefix":"10.1016","volume":"121","author":[{"given":"Catherine","family":"Th\u00e9riault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Pinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Comamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Migneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Beaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Matte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pich\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Rancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.02.020_bb0005","first-page":"71","article-title":"Cancer statistics, 2009","volume":"49","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0010","first-page":"297","article-title":"Epithelial ovarian cancer: prevention, diagnosis, and treatment","volume":"49","author":"Partridge","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1984.254","article-title":"Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker","volume":"50","author":"Canney","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9378(87)80352-6","article-title":"Evaluation of serum CA 125 levels in the monitoring of ovarian cancer","volume":"157","author":"Vergote","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ajcp\/79.1.98","article-title":"Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types","volume":"79","author":"Kabawat","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","article-title":"CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From the Danish \"MALOVA\" Ovarian Cancer Study","volume":"104","author":"Hogdall","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1071-5576(99)00027-1","article-title":"Ovarian cancer antigen CA125 enhances the invasiveness of the endometriotic cell line EEC 145","volume":"6","author":"Gaetje","year":"1999","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0050","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ygyno.2005.07.030","article-title":"Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125","volume":"99","author":"Patankar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2009.08.007","article-title":"CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis","volume":"115","author":"Boivin","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0065","first-page":"6143","article-title":"Characterization of the CA125 antigen associated with human epithelial ovarian carcinomas","volume":"46","author":"Davis","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000217821","article-title":"Purification and characterization of the CA125 tumor-associated antigen from human ascites","volume":"14","author":"MT","year":"1993","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9378(93)90652-Y","article-title":"Molecular characteristics of the CA125 antigen produced by human endometrial epithelial cells: comparison between eutopic and heterotopic epithelial cells","volume":"169","author":"Kobayashi","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000217844","article-title":"Characterization of CA125 synthesized by the human epithelial amnion WISH cell line","volume":"14","author":"Fendrick","year":"1993","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000217716","article-title":"Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen","volume":"12","author":"Nagata","year":"1991","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0090","doi-asserted-by":"crossref","first-page":"27371","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin (Muc16)","volume":"276","author":"Yin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.10250","article-title":"Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene","volume":"98","author":"Yin","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0100","doi-asserted-by":"crossref","first-page":"28619","DOI":"10.1074\/jbc.M302741200","article-title":"Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125","volume":"278","author":"Kui Wong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000050638","article-title":"The CA125 gene: an extracellular superstructure dominated by repeated sequences","volume":"22","author":"O'Brien","year":"2001","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000064032","article-title":"The CA125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure","volume":"23","author":"O'Brien","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.ph.57.030195.003135","article-title":"Epithelial mucin genes","volume":"57","author":"Gendler","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0","article-title":"Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule","volume":"88","author":"Satoh","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/0008-5472.CAN-03-2636","article-title":"Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis","volume":"64","author":"Singh","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.onc.1204106","article-title":"Muc4\/sialomucin complex, an intramembrane modulator of ErbB2\/HER2\/Neu potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor","volume":"20","author":"Komatsu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.129.1.255","article-title":"Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components","volume":"129","author":"Wesseling","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jcp.21223","article-title":"Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression","volume":"213","author":"Hugo","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0150","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1242\/jcs.02552","article-title":"Epithelial-mesenchymal transition","volume":"118","author":"Radisky","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumor progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","article-title":"Cell adhesion and signaling by cadherins and Ig-CAMs in cancer","volume":"4","author":"Cavallaro","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0170","first-page":"4086","article-title":"Identification of germ-line E-cadherin mutations in gastric cancer families of European origin","volume":"58","author":"Gayther","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0180","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.270.5239.1203","article-title":"Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin","volume":"270","author":"Hermiston","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0185","first-page":"7057","article-title":"Truncation of the extracellular region abrogates cell contact but retains the growth-suppressive activity of E-cadherin","volume":"60","author":"Sasaki","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0190","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via \u03b15-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1083\/jcb.147.3.631","article-title":"N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression","volume":"147","author":"Nieman","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<842::AID-IJC24>3.0.CO;2-8","article-title":"Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule","volume":"71","author":"Lloyd","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0205","first-page":"2134","article-title":"Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7","volume":"58","author":"Pich\u00e9","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.cgt.7700117","article-title":"Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562","volume":"7","author":"Kasono","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.2910580315","article-title":"Differential expression of the cell\u2013cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells","volume":"58","author":"Veatch","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0220","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","article-title":"Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases","volume":"28","author":"Darai","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0225","article-title":"MUC-4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells","author":"Ponnusamy","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0230","first-page":"2547","article-title":"Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells","volume":"11","author":"Miyaki","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1083\/jcb.142.2.557","article-title":"E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27kip1","volume":"142","author":"St Croix","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0240","first-page":"5011","article-title":"Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line","volume":"63","author":"Kohlgraf","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0245","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1206291","article-title":"MUC1 alters \u03b2-catenin-dependent tumor formation and promotes cellular invasion","volume":"22","author":"Schroeder","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0250","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1074\/jbc.M011248200","article-title":"Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland","volume":"276","author":"Schroeder","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2011.02.020_bb0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/107155769400100118","article-title":"Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line","volume":"1","author":"Konishi","year":"1994","journal-title":"J Soc Gyn Invest"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:26:15Z","timestamp":1758770775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0090825811001405"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}